Basile, G., Galtier, J., Cazaubiel, T., Forcade, E., Klein, E., Bidet, A., . . . Leguay, T. Relapsed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia responds well to a combination of modified hyper‐CVAD, blinatumomab and tyrosine kinase inhibitor. Wiley.
Chicago Style (17th ed.) CitationBasile, Gaétan, et al. Relapsed Philadelphia Chromosome‐positive B‐cell Acute Lymphoblastic Leukaemia Responds Well to a Combination of Modified Hyper‐CVAD, Blinatumomab and Tyrosine Kinase Inhibitor. Wiley.
MLA (9th ed.) CitationBasile, Gaétan, et al. Relapsed Philadelphia Chromosome‐positive B‐cell Acute Lymphoblastic Leukaemia Responds Well to a Combination of Modified Hyper‐CVAD, Blinatumomab and Tyrosine Kinase Inhibitor. Wiley.
Warning: These citations may not always be 100% accurate.